Catalyst Wire Dossier Catalyst Wire Dossier

EBV-derived dendritic cell vaccine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EBV-derived dendritic cell vaccine, covering 2016-11-01 to 2016-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant [Phase 2]

See pricing